Biodel Inc. To Present VIAject(TM) Clinical Progress At The 2007 American Diabetes Association Meeting
06/21/07
Biodel Inc. (Nasdaq:
BIOD) today announced plans to present clinical results of its leading
product candidate, VIAject(TM), at the 67th Annual American Diabetes
Association (ADA) Scientific Sessions, to be held in Chicago, June 22
through June 26.
Biodel's oral presentation at the ADA will take place on June 22 from
4:15 - 6:15pm CST, a summary of which will be available on Biodel's
website. Following the presentation, the Company will host an investor
briefing. Interested parties may access a link to a live audio webcast of
the investor briefing in the investor section of Biodel's website at
(Author: http://www.biodel.com)
| << Prev | Pharmacy News Home | Next>> |
|---|
